Timothy Hoey, SVP, Cancer Biology at OncoMed Pharmaceuticals Inc (OMED), sold 2,500 shares at $22.30 ($54K) on 2014-08-05, disclosed to the SEC on 2014-08-07.
Scheduled sale ($54k) by SVP, Cancer Biology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.61 | 2,300 | $50K | 91.8% |
| 2 | $22.30 | 200 | $4K | 8.2% |
| Total | $21.67 avg | 2,500 | $54K | 100% |
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |